[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590314":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":29,"collaborators":7,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":35,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":7,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":59},{"fullName":5,"class":6},"Cedars-Sinai Medical Center","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Mathew P Monterola, Doctor of Nursing Practice","CONTACT","3109677434","Mathew.Monterola@cshs.org",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":7},"Cedars-Sina Medical Center","RECRUITING","Los Angeles","California","90048","United States","US",{"type":24,"coordinates":25},"Point",[26,27],-118.24368,34.05223,{"lat":27,"lon":26},{"type":30,"investigatorFullName":31,"investigatorTitle":32,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Matthew Monterola","Associate Director, Clinical Support Programs","100590314","this-study-is-to-evaluate-whether-receiving-education-and-glucose-monitoring-with-the-cgm-device-will-improve-patient-reported-outcomes-by-improving-patients-satisfaction-and-quality-of-life-qol-with-glucose-monitoring-device-100590314",false,"NCT06965803","This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device","Continuous Glucose Monitor (CGM) Discharge Program","CGM QOL","Inclusion Criteria:\n\n* aged 18 or older\n* diagnosed with Type 1 or Type 2 Diabetes who are on insulin\n* able to speak and understand English language\n* scheduled to receive a standard inpatient diabetes education consultation\n* must not have used CGM in the six months prior to admission\n* owns a smartphone\n* demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program\n\nExclusion Criteria:\n\n* those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices.\n* non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources\u002Ftranslations\u002Fpersonnel for evaluation and the education intervention that are not logistically possible right now.","ALL","18 Years",{"count":44,"type":45},37,"ESTIMATED","OBSERVATIONAL","The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.",[49],"Diabetes Mellitus","2026-03-16",{"date":52,"type":53},"2026-03-18","ACTUAL",{"date":55,"type":53},"2025-10-01",{"date":57,"type":45},"2026-12-30",{"name":5,"class":6},1]